Loading…

Olympus Corporation finalized the acquisition of Medi-Tate Ltd., an Israeli medical device company specializing in minimally invasive treatment for benign prostatic hyperplasia (BPH). The acquisition expands Olympus's urology portfolio with the iTind device.
“Olympus Corporation announced today that it has finalized the acquisition of Israeli medical device company Medi-Tate Ltd.”businesswire.com
Summarized from public sources; check the original articles before acting on it.